Survival analysis indicated that high expression of TOP2A, TYMS, FEN1, PRC1, or UBE2C gene significantly decreased disease-free survival of patients with other thyroid carcinomas (Figure 5). This evidence concerns the gene FEN1 and thyroid gland carcinoma.